Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects

PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay

Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics

Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives